Earnings season is always highlighted in a trader’s calendar. These few weeks are the most exciting and potentially profitable periods of the year for stock market watchers as shares that are traditionally quiet experience significant share price moves on a daily basis. And this season is no different. When shares rally, they typically see a…
AstraZeneca’s Mystic drug trial failure and 15% share price drop (biggest ever fall) has understandably hogged this week’s headlines. And this means that the performance of a key sector – a retail investor favourite – has slipped under the radar, despite rather impressive gains of 3-12%, easily outperforming the UK 100 index of blue-chips which…
Macro observations With the Euro on a tear against its Anglo-American counterparts, this week investors will be keeping an eye out for an all-important trend change. Against the US Dollar, the European single currency is trading at a 23-month high and threatening to break out of a significant trading range. The Euro hasn’t traded above…
The UK Index airlines sector has had a tough week, shares falling 1.5% to 13% to keep investors on their toes but also offer multiple trading opportunities. Our position at the market coalface has once again proved invaluable to clients, allowing us communicate on the many drivers in play, providing clients with an opportunity to…
Hold on to your hats, because next week we see earnings season kick into top gear. With 31 of the UK’s largest blue chip index companies reporting figures, for a total of a whopping 45% by weight, we’re in for one hell of a ride. With so many UK 100 companies reporting, could we even…
Macro observations Following the pivotal events last week for the US dollar, it’s time for Europe to take over. The greenback has sunk to fresh 10-month lows following the latest spate of weaker-than-expected macroeconomic data, but can the European Central Bank continue to take the gloss off the world’s reserve currency? On Thursday the Governing…